Company Logo Dublin, Nov. 19, 2026 (GLOBE NEWSWIRE) -- "Generative AI in Clinical Trials - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global generative AI in clinical trials market was valued at US$237.2 billion in 2025 and is projected to reach US$964.2 billion by 2032, expanding at a compound annual growth rate (CAGR) of 22.2%. Growth is being supported by increased adoption of adaptive trial design, AI-enabled patient recruitment, synthetic clinical data, predictive safety monitoring and decentralized clinical trial models. Adaptive, Data-Guided Clinical Trial Design Clinical development is moving from fixed protocols toward adaptive strategies that analyze historical and real-time study data.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
